1. Home
  2. PROV vs SLDB Comparison

PROV vs SLDB Comparison

Compare PROV & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROV
  • SLDB
  • Stock Information
  • Founded
  • PROV 1956
  • SLDB 2013
  • Country
  • PROV United States
  • SLDB United States
  • Employees
  • PROV N/A
  • SLDB N/A
  • Industry
  • PROV Savings Institutions
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PROV Finance
  • SLDB Health Care
  • Exchange
  • PROV Nasdaq
  • SLDB Nasdaq
  • Market Cap
  • PROV 103.5M
  • SLDB 464.1M
  • IPO Year
  • PROV 1996
  • SLDB 2018
  • Fundamental
  • Price
  • PROV $15.84
  • SLDB $6.32
  • Analyst Decision
  • PROV Hold
  • SLDB Strong Buy
  • Analyst Count
  • PROV 1
  • SLDB 10
  • Target Price
  • PROV $16.50
  • SLDB $15.00
  • AVG Volume (30 Days)
  • PROV 11.3K
  • SLDB 1.3M
  • Earning Date
  • PROV 10-24-2025
  • SLDB 11-05-2025
  • Dividend Yield
  • PROV 3.54%
  • SLDB N/A
  • EPS Growth
  • PROV N/A
  • SLDB N/A
  • EPS
  • PROV 0.93
  • SLDB N/A
  • Revenue
  • PROV $39,666,000.00
  • SLDB N/A
  • Revenue This Year
  • PROV $7.74
  • SLDB N/A
  • Revenue Next Year
  • PROV $4.06
  • SLDB N/A
  • P/E Ratio
  • PROV $16.99
  • SLDB N/A
  • Revenue Growth
  • PROV 1.90
  • SLDB N/A
  • 52 Week Low
  • PROV $12.98
  • SLDB $2.41
  • 52 Week High
  • PROV $16.70
  • SLDB $7.37
  • Technical
  • Relative Strength Index (RSI)
  • PROV 45.88
  • SLDB 57.36
  • Support Level
  • PROV $15.57
  • SLDB $5.81
  • Resistance Level
  • PROV $15.95
  • SLDB $6.79
  • Average True Range (ATR)
  • PROV 0.16
  • SLDB 0.45
  • MACD
  • PROV -0.03
  • SLDB 0.06
  • Stochastic Oscillator
  • PROV 8.91
  • SLDB 70.79

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: